Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 26,865 | 0 | 0 | 40,560 | 0 |
| Gross Profit | 26,865 | N/A | N/A | 40,560 | N/A |
| Operating Expenses | 76,714 | 51,432 | 65,148 | 65,325 | 67,922 |
| Operating Income | -49,849 | -51,432 | -65,148 | -24,765 | -67,922 |
| Other Income | 2,172 | 11,247 | -22,863 | 34,948 | 6,848 |
| Pre-tax Income | -47,677 | -40,185 | -88,011 | 10,183 | -61,074 |
| Income Tax | -205 | -27 | 266 | 143 | -135 |
| Net Income Continuous | -47,472 | -40,158 | -88,277 | 10,040 | -60,939 |
| Minority Interests | N/A | N/A | N/A | -28 | -22 |
| Net Income | $-47,472 | $-40,158 | $-88,277 | $10,068 | $-60,917 |
| EPS Basic Total Ops | -0.67 | -0.56 | -1.24 | 0.14 | -0.76 |
| EPS Basic Continuous Ops | -0.67 | -0.56 | -1.24 | 0.14 | -0.76 |
| EPS Diluted Total Ops | -0.67 | -0.56 | -1.24 | 0.14 | -0.76 |
| EPS Diluted Continuous Ops | -0.67 | -0.56 | -1.24 | 0.14 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.56 | -1.24 | N/A | N/A |
| EBITDA(a) | $-47,193 | $-52,756 | $-67,017 | $-27,205 | $-72,140 |